HomeHEMO • LON
add
Hemogenyx Pharmaceuticals PLC
Previous close
GBX 1.57
Day range
GBX 1.52 - GBX 1.60
Year range
GBX 1.10 - GBX 7.13
Market cap
21.13M GBP
Avg Volume
7.63M
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
(GBP) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.12M | -21.18% |
Net income | -1.18M | 16.90% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -856.86K | 39.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(GBP) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.25M | -50.74% |
Total assets | 6.11M | -13.91% |
Total liabilities | 3.32M | -13.62% |
Total equity | 2.78M | — |
Shares outstanding | 1.19B | — |
Price to book | ∞ | — |
Return on assets | -46.05% | — |
Return on capital | -49.10% | — |
Cash Flow
Net change in cash
(GBP) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.18M | 16.90% |
Cash from operations | -1.36M | -38.50% |
Cash from investing | -36.74K | 82.53% |
Cash from financing | 424.74K | 911.34% |
Net change in cash | -918.63K | 43.76% |
Free cash flow | -539.11K | 47.22% |
About
Founded
2012
Website
Employees
17